Certara’s Post

Digital health has the potential to contribute enormously to healthcare delivery and improve patient outcomes, yet the reimbursement pathways for digital health in Asia-Pacific are not well defined and follow existing value frameworks that are mostly incompatible. This is leading to no/low coverage and health inequities in access to digital health. Our latest whitepaper, co-authored by Asia Pacific Medical Technology Association (APACMed), sheds light on the current state of reimbursement in key Asia-Pacific markets and contrasts it with much better access to digital health in European countries. Discover insights and perspectives of policymakers, experts, and academics from Singapore, Japan, South Korea, Australia, Germany, France, and the UK. Download your copy now and stay ahead in the ever-evolving world of digital health: https://ow.ly/E6y150PRrpM. #DigitalHealth #APAC #Reimbursement #HealthcarePolicy

One of the key changes to the health technology assessment (HTA) guidance in the Netherlands is greater acceptance of structured expert elicitation (SEE) and clearer guidelines on what is and is not appropriate in submissions. In our article, published earlier this year, our team summarizes the key changes and delves into the guidelines around SEE – key reading for health technology manufacturers seeking reimbursement in the Netherlands. Read our article here: https://buff.ly/4ch8FXm #LumanityPerspectives #HEOR #HealthEconomics #HTA #ZIN #SEE

Significant changes are on the horizon for Spain’s healthcare sector, encompassing funding trends and regulatory updates. Find out how pharmaceutical funding decisions are changing, the recent patterns in funding approvals, and what proactive steps manufacturers can take to navigate these shifts effectively

Health technology assessment plays a crucial role in evaluating the clinical effectiveness, safety, and cost-effectiveness of new #healthtechnologies. By systematically reviewing and analyzing the available evidence, HTA helps decision-makers, including #policymakers, #healthcareproviders, and payers, make informed choices about the adoption, reimbursement, and utilization of healthcare interventions. Through HTA, #stakeholders can assess the potential benefits and risks of implementing new #technologies, ensuring that resources are allocated efficiently and that patients receive the most appropriate and effective treatments. HTA promotes #transparency and #accountability in healthcare decision-making by providing evidence-based recommendations supported by rigorous scientific analysis. By considering factors such as clinical outcomes, patient preferences, and economic implications, HTA helps optimize healthcare resource allocation, ultimately leading to improved patient outcomes and better overall #healthcaredelivery. Overall, HTA serves as a valuable tool for driving evidence-based decision-making and maximizing the value of healthcare investments. #technologyassessment #techadoption #healthtech #healthtechtools #remotecare

Wondering about the upcoming changes in Spain’s healthcare landscape? Our experts discuss how emerging funding patterns and regulatory shifts will impact access to medicines in the country’s near future. Read all about this on our latest blog: skp.link/dwr #BetterMarketAccess #Healthcare #Spain #SimonKucher

How can #healthtech companies better navigate the commercial payer landscape? Earlier this year, the MDIC Commercial Payer Council convened for its inaugural quarterly session. Led by Harry Kotlarz, Vice President of MDIC’s Health Economics and Patient Value (HEPV) program, the meeting brought together a diverse panel of industry leaders—from integrated healthcare networks to device companies, health plan executives to legal experts. Together, they explored the intricacies of navigating Medicare Advantage and reimbursement for digital health technologies. Explore the Key Insights summary of topics discussed designed to guide #medicaldevice and #digitalhealth tech companies in navigating the landscape of commercial payers: https://lnkd.in/ejRywsYP #medicare #medicareadvantage #reimbursement #marketaccess #medicaldevices #medtech #digitalhealth

People want a fix to crazy healthcare prices Unfortunately, they focus on quick wins. I'm not convinced. Not when it comes to healthcare costs. While many disagree with me, I think there's "secret sauce"? Disrupt the status quo. Play the long game! This long game → Accountability. Enforcement. Affordability. Think accountability, not confusion. Think enforcement, not laissez-faire Think affordability, not profits over people Here's my advice: + Prioritize preventive care. + Increase telehealth access. + Eliminate pharmacy gag rules. + Expand access to generic drugs. + Keep the donut-hole relief in place. + Allow safe importation of cheaper drugs. + Standardize pricing for simple comparison. + Disclose all healthcare related costs up front. + Empower consumers to compare prices everywhere. Quick fixes are a nice dopamine fix, but they won't solve the this issue. Win the long game, my friends. P.S. What's your top strategy for improving healthcare price transparency?

🔍 Stay Ahead in Healthcare! Dive into our latest blog where we unpack the most impactful regulatory and policy changes shaping healthcare today: 📊 Price Transparency Mandates – Discover how new CMS rules are empowering patients with clear pricing information. 💊 Reforms in Drug Pricing Programs – Learn about the Medicare changes and cost caps making drugs more affordable. 🏥 Shift Toward Value-Based Care – Understand how value-based models are revolutionizing care and rewarding quality over quantity. Don't miss out on these crucial insights—click the link to explore how these changes can affect your practice or healthcare organization https://lnkd.in/e2Z7bP7U #DrugPricing #Health #PriceTransparency #Reforms #CareModels

Following the success of the Asia Pacific Medical Technology Association (APACMed) Digital Health Reimbursement Alliance (DHRA) Forum, a number of outcomes have emerged which will help us on our journey to reshape the healthcare landscape across Asia Pac. Take a look below at 5 key DHRA initiatives and projects on the horizon. John Collings, Probir Das, Chee Hong L., Farhana Nakhooda, Steven Flynn, Vy Tran, Alex Gu, Justin Leong, Tim Schmid, Lance Little, Stephen Morse Marc Radatt, Paul Tan, Pavan Kumar Mocherla Harjit Gill Roberta Sarno, Anirudh Sen, Sam Collings, Anh BOURCET, Chris L. Hardesty, Arif Fahim, Julianna Yeung, Jamie Kebely, Mary Kiang, Michael Nobes, PhD #digitalhealth #digitalhealthcare #digitalhealthreimbursement #healthcare #healthtech #healthequity #digitalhealthsolutions #digitaltherapeutics #Dtx #equitableaccess #medicaldevices #DHRA #medtech

Our amazing COO Eugene Borukhovich will be co-hosting HealthXL webinar "The New Frontier of High-Tech and High-Touch in Patient Support Programs" together with Stacey Meltzer Wasserman, CBO at Medisafe® Connected Health Platform. Sign up below to learn more about: ● Falling Short: Why is there a gap in integrated healthcare services?  ● The New Era in Patient Care: What will this look like? How does a combination of high-tech and high-touch care help patients achieve better #health outcomes?  ● Moving the Needle: What value do #healthcoaches bring to the table? Why does integrating a human element into #digitalmedication management make sense? ● Holistic Management of the #patientjourney: Why should pharma companies prioritize #holisticcare throughout their patients’ treatment journeys? https://lnkd.in/dr54UUZr #digitalhealth #pharma #healthcoaching #integratedcare #outcomes